Elekta to sell its MEG business to York Instruments

STOCKHOLM, July 19, 2018 – Elekta (EKTA-B.ST) announced today that it has signed an agreement to sell its MEG business to York Instruments, a subsidiary of Croton Healthcare, LLC. This divestment follows Elekta’s strategic decision to prioritize its treatment solutions and oncology informatics portfolio.

MEG is a diagnostic functional neuroimaging technique for mapping brain activity. This can be applied in a clinical setting to find locations of abnormalities as well as in a research setting to simply measure brain activity. Elekta’s MEG business, known as MEGIN, is a leading supplier of magnetoencephalography (MEG) technology, with more than 100 delivered MEG systems worldwide.

More info

York Instruments now able to capture MEG data at ultra-high sample rates

York Instruments has acquired data, synchronously across all 320 sensor channels, at an astonishing 81000 samples per second with 24-bit ADC.

This ultra-high sample rate will allow MEG users to characterise data in high frequency bands with unsurpassed accuracy. Researchers working on ultra-high frequency oscillations will welcome this breakthrough in speed of acquisition. There is emerging evidence of a range of clinical biomarkers in neurological and psychiatric conditions which are detectable in the high frequency range from100hz to over 1 kHz. MEGSCAN will be a powerful tool for clinicians diagnose and characterise a range of clinical disorders, and puts MEG technology at the forefront of imaging.

York Instruments attends the 31st International Congress of Clinical Neurophysiology (ICCN)

May 1-6 2018. York Instruments attended ICCN 2018 which was held at the Marriott Wardman Park Hotel in Washington DC. Co-hosted by the American Clinical Neurophysiology Society (ACNS) and the Canadian Society of Clinical Neurophysiologist (CSCN), this event was held in conjunction with the annual meeting of the American Clinical Magnetoencephalograhpy Society (ACMEGS). With delegates attending from the United States, South America, Europe, the middle east, China and Japan this was truly an international gathering on a grand scale.

Directed at those practicing or training in the fields of Neurophysiology and Neurology, the comprehensive programme of talks covered a broad spectrum of clinical and research topics. The congress aimed to deliver an improved understanding of the use of current and developing clinical neurophysiological techniques in the diagnosis and management of disorders of the nervous system.

York Instruments attends 50 Years of MEG celebration with ISACM

April 20-21 2018. York Instruments attended the formal celebration of 50 years of magnetoencephalography since David Cohen took his first MEG reading in 1968. This was held on the beautiful island of Poros in Greece. The meeting was coorganised by the International and European Societies of Magntoencephalography and drew together a range of clinical users of MEG from Europe, US and Asia. The goal of the meeting as to assess the current status and future directions of MEG technology and its clinical and research applications.

Professor Gary Green from York Instruments presented on overview of the exciting new system MEGSCAN – which will be launched later this year. As well as offering an unprecedented combination of modern sensors, cryogenics , electronics and software, MEGSCAN looks to open a new chapter for MEG worldwide as it will open a range of new clinical applications for MEG.

York Instruments Signs Agreement for Three Magnetoencephalography Systems with Consortium of Leading Universities

YORK UK, Aug. 8, 2017—York Instruments, Ltd. (subsidiary of Croton Healthcare, LLC, Coral Springs, Florida) has signed agreements to place magnetoencephalography (MEG) systems at three leading neuroscience research universities in the UK and Germany. The University of York and the University of Glasgow in the UK and Germany’s University of Konstanz will partner closely with York Instruments to develop the ground-breaking technology, as well pursue potential new applications using the company’s recently released MEG technology.

The agreement expands upon a development partnership started in 2015. By first incorporating MEGSCAN™ core control electronics, the universities’ MEG researchers will achieve an improved signal to noise ratio through ground breaking low noise electronics. With the full MEGSCAN™ system, the universities will end their reliance on expensive liquid helium, a dwindling non-renewable resource, and have the capability to measure healthy and pathological brain signals with unprecedented sensitivity.

York Instruments’ CEO Gordon Baltzer said, “We are very pleased to be able to invite the Universities of York, Glasgow and Konstanz to be part of our growing network of pioneering MEG research and clinical sites worldwide looking to radically improve the field of MEG.”

More info

York Instruments receives first order for its magnetoencephalography instrument from the University of Texas Southwestern Medical Center

March 21, 2017 (York UK) —York Instruments Ltd. (subsidiary of Croton Healthcare, LLC, Coral Springs, FL) has received its first order for a MEGSCAN™ magnetoencephalography (MEG) instrument. The purchase was made by the prestigious University of Texas Southwestern Medical Center in Dallas, Texas (UTSW). York Instruments’ newly developed MEG system maps brain activity by recording magnetic fields produced by electrical currents occurring naturally in neurons of the brain.

York Instruments’ Vice President of Global Sales and Marketing Gordon Haid said, “We are extremely happy to be working closely with the talented individuals at UTSW as we install York Instruments’ new MEG platform. As the first member of our MEGSCAN™ beta site program, we expect to collaborate extensively with UTSW on the development of the technology and expanding indications for MEG.”

The MEGSCAN™ will be installed at UTSW later this year, where it will be used for both neuroscience research and eventually routine clinical evaluations of patients suffering from epilepsy and other debilitating illnesses. The system incorporates patented HyQUID™ sensor technology in a liquid helium-free cryogenic environment, high-density cortical coverage, integrated simultaneous EEG, new state of the art electronics capability and an advanced software infrastructure.

More info

York Instruments presents at ACMEGS 2017

York Instruments attended the annual American Clinical MEG Society (ACMEGS) conference in Phoenix, Arizona on February 9 to present the latest developments of the company and the MEGSCAN system.

The primary objective of ACMEGS is to support MEG service providers with facility and business operations by networking patients, physicians, and health care administrators with MEG providers. They educate members and other organizations about varying rules, regulations, and reimbursement matters that affect the success of MEG facilities in the US. The society collaborates with ACNS, NAES, AAN, AES and others on matters affecting patient care. Furthermore, they work on new applications of MEG to improve the health of all patients who would benefit from this technology.

York Instruments announces collaboration with eemagine GmbH in MEG-EEG instrumentation and software development

February 8, 2017 (York, UK) – Officials from York Instruments Ltd (subsidiary of Croton Healthcare, LLC, Coral Springs, FL) announced today that the company has entered into an agreement with eemagine GmbH for the development of high performance integrated solutions to study human electromagnetic brain activity using magnetoencephalography (MEG) and electroencephalography (EEG) for research and clinical diagnostics.

This joint effort enables York Instruments to provide users with high-resolution EEG measurements and clinical analysis software, which complements the company’s advanced MEG solutions.

York Instruments’ President James R. Petite Jr. said, “The collaboration with eemagine GmbH is an important milestone toward the upcoming release of York instruments’ MEGSCAN complete package solution.”

More info

York Instruments attends AES annual meeting in Texas

American Epilepsy Society (AES) allows epilepsy clinicians and researchers from around the world to share the most up to date information on clinical resources, epilepsy research and patient support. York Instruments had a strong presence at this years’ meeting, sharing the latest on our new MEGSCAN instrument with doctors and university attendees. The AES meeting took place in Houston Texas from Dec 2nd to Dec 6th.

Epileptologists and neurosurgoens agree that magnetoencephalography is a powerful and effective tool for use in localising epileptic activity:

  • Non-invasive tool to localize epileptic activity & brain function
  • Leads to improved surgical outcomes
  • Direct measure of electrophysiology
  • Data undistorted by the skull & scalp
  • Millimeter / millisecond accuracy

York Instruments unveils MEGSCAN design at Biomag

During the 20th International Conference on Biomagnetism (BIOMAG2016), recently held in Seoul, Korea, York Instruments unveiled images of the groundbreaking MEGSCAN instrument.  Attendees universally had a strong positive reaction to the design, along with the specification highlights:

  • 320 axial gradiometer or magnetometer sensors, each at an independent location over the surface of a whole-cortex helmet.  The highest density, and therefore highest spatial resolution, of any commercially available MEG.
  • Alternate head sizes available as a build-time option, for example for pediatric MEG.
  • 32 reference channels for superior environmental interference cancellation, even at noisy sites.
  • HyQUID detectors with better low frequency and white noise performance than traditional SQUIDs.  Also, HyQUIDs do not need to be retuned while the system is cold.
  • Seated and supine measurement position with separate bed and chair, conveniently accommodating various subject sizes.
  • Cooling via a vibration-free pulse tube, so the system is entirely liquid Helium free.  No expensive liquid helium deliveries; no time-consuming refilling; no complicated and costly recycling.